Abingworth LLP Soleno Therapeutics Inc Transaction History

Abingworth LLP

  • $301 Million
  • Q4 2022

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
BUY
$0.22 - $0.47 $1.7 Million - $3.63 Million
7,720,000 Added 74.93%
18,022,602 $3.97 Million
Q2 2020

Aug 14, 2020
BUY
$1.77 - $4.23 $5.9 Million - $14.1 Million
3,333,330 Added 47.83%
10,302,602 $22.8 Million
Q4 2019

Feb 14, 2020
BUY
$1.35 - $2.95 $3.11 Million - $6.79 Million
2,300,000 Added 49.26%
6,969,272 $19.9 Million
Q4 2018

Feb 14, 2019
BUY
$1.55 - $2.3 $7.24 Million - $10.7 Million
4,669,272 New
4,669,272 $7.98 Million

About SOLENO THERAPEUTICS INC

SLNO Quotes by TradingView
  • Ticker SLNO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 8,101,250
  • Market Cap $441M
  • Description
  • Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Controlled-Release, a once-daily oral tablet for the treatment of Prader-Willi Syndrome, which is being evaluated in an ongoing P...
More about SLNO
Track This Portfolio

Track Abingworth LLP Portfolio

Follow Abingworth LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Abingworth LLP, based on Form 13F filings with the SEC.

News

Stay updated on Abingworth LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email